Summary

Intravenous Iron Drugs Market Growth & Trends

The global intravenous iron drugs market size is expected to reach USD 4.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The introduction of novel formulations with expanded indications, increasing R&D activities, and rising awareness for diagnosis and treatment of anemia is expected to propel market demand over the forecast period.

The increase in the prevalence of chronic diseases, such as chronic kidney disease, cancer, inflammatory bowel diseases, diabetes, and acute and chronic infections, has been a major market driver facilitating a significant demand for intravenous iron drugs. According to the Globol can estimates, in 2020, around 19,292,789 new cases of cancer were diagnosed globally, which lead to around 9,958,133 deaths in the same year. According to the data published by the CDC, in 2019, an estimated 15% of U.S. adults, or around 37 million adults, are suffering from chronic kidney disease (CKD). The same source also stated that diabetes and high blood pressure are the major causes of CKD in adults, and CKD is more common in people aged 65 years or older. The rise in the incidence of chronic kidney disease globally, due to unhealthy lifestyles, has been a major growth factor for the market.

Furthermore, increasing approval and indication expansion of iron drugs in key markets has significantly supported market growth. In February 2021, Pharmacosmos announced that the National Medical Products Administration (NMPA) approved Monofer injection 100 mg/mL in China. Also, in February 2018, the company announced that the U.S. FDA approved Supplemental New Drug Application (sNDA) for Feraheme (ferumoxytol injection). The FDA approved the use of Feraheme by an eligible adult suffering from Iron Deficiency Anemia (IDA).

Intravenous Iron Drugs Market Report Highlights

• Effects of the ongoing pandemic have also shown an estimated 14.0% to 30.0% kidney function loss among COVID-19 patients. Thus, increased the demand for iron drugs for the management of kidney disease-induced anemia in COVID-19 patients

• The Ferric Carboxymaltose segment accounted for the largest revenue share in 2020. Its high share is attributed to the high revenue generation of Ferinject/Injectafer in key markets

• The Chronic Kidney Disease (CKD) segment dominated the market in 2020. Its leading share is attributed to the increasing prevalence of CKD and the high incidence of IDA among CKD patients

• Key players are undertaking extensive strategic initiatives in the market, such as mergers and acquisitions, new product developments, and regional expansion, to address the growing demand

• North America dominated the market with the largest revenue share in 2020. The presence of major players and favorable reimbursement scenarios are facilitating the dominance of this region during the study period

• Asia Pacific is projected to witness a lucrative CAGR owing to the high prevalence of IDA in emerging economies

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Intravenous Iron Drugs Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing prevalence of target diseases
3.3.1.2 Increasing prevalence of iron deficiency anemia
3.3.1.3 Disadvantages of oral iron drugs
3.3.2 Market Restraint Analysis
3.3.2.1 Side effects associated with iron drugs
3.3.3 Industry challenges
3.4 Intravenous Iron Drugs Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
3.5 COVID-19 Impact on Intravenous Iron Drugs Market
Chapter 4 Intravenous Iron Drugs Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.3 Public Companies
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Intravenous Iron Drugs Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Global Intravenous Iron Drugs Market, by Product, 2016 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.5.1 Iron Dextran
5.5.1.1 Iron Dextran Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.2 Iron Sucrose
5.5.2.1 Iron Sucrose Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3 Ferric Carboxymaltose
5.5.3.1 Ferric Carboxymaltose Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.4 Others
5.5.4.1 Others Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 6 Intravenous Iron Drugs Market: Application Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Application Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Global Intravenous Iron Drugs Market, by Application, 2016 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
6.5.1 Chronic Kidney Disease
6.5.1.1 Chronic Kidney Disease Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.2 Inflammatory Bowel Disease
6.5.2.1 Inflammatory Bowel Disease Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.3 Cancer
6.5.3.1 Cancer Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.4 Others
6.5.4.1 Others Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 7 Intravenous Iron Drugs Market: Regional Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Regional Market Share and Leading Players, 2020
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa
7.3 Market Share Analysis by Country, 2020
7.3.1 North America
7.3.1.1 U.S.
7.3.1.2 Canada
7.3.2 Europe
7.3.2.1 U.K.
7.3.2.2 Germany
7.3.2.3 Spain
7.3.2.4 France
7.3.2.5 Italy
7.3.2.6 Russia
7.3.3 Asia Pacific
7.3.3.1 Japan
7.3.3.2 China
7.3.3.3 India
7.3.3.4 South Korea
7.3.3.5 Singapore
7.3.3.6 Australia
7.3.4 Latin America
7.3.4.1 Brazil
7.3.4.2 Mexico
7.3.4.3 Argentina
7.3.5 Middle East & Africa
7.3.5.1 South Africa
7.3.5.2 Saudi Arabia
7.3.5.3 UAE
7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific
7.4.4 Latin America
7.4.5 Middle East & Africa
7.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2028
7.5.1 North America
7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.1.3 Canada
7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.2 Europe
7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.2.2 U.K.
7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.2.3 Germany
7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.2.4 Spain
7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.2.5 France
7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.2.6 Italy
7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.2.7 Russia
7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.3 Asia Pacific
7.5.3.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.3.2 Japan
7.5.3.2.1 Japan Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.3.2.2 Japan Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.3.3 China
7.5.3.3.1 China Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.3.3.2 China Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.3.4 India
7.5.3.4.1 India Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.3.4.2 India Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.3.5 South Korea
7.5.3.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.3.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.3.6 Singapore
7.5.3.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.3.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.3.7 Australia
7.5.3.7.1 Australia Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.3.7.2 Australia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.4 Latin America
7.5.4.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.4.2 Brazil
7.5.4.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.4.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.4.3 Mexico
7.5.4.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.4.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.4.4 Argentina
7.5.4.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.4.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.5 Middle East & Africa
7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.5.3 Saudi Arabia
7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
7.5.5.4 UAE
7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2028 (USD million)
7.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2028 (USD million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 AMAG Pharmaceuticals
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 AbbVie, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Daiichi Sankyo Company, Ltd.
8.1.3.1 American Regent. Inc.
8.1.3.1.1 Company overview
8.1.3.1.2 Financial Performance
8.1.3.1.3 Product benchmarking
8.1.3.1.4 Strategic initiatives
8.1.4 Sanofi
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Vifor Pharma Management Ltd.
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Pharmacosmos A/S
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Shield Therapeutics Plc.
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives


List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America intravenous iron drugs market, by country, 2016 - 2028 (USD Million)
Table 4 North America intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 5 North America intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 6 U.S. intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 7 U.S. intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 8 Canada intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 9 Canada intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 10 Europe intravenous iron drugs market, by country, 2016 - 2028 (USD Million)
Table 11 Europe intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 12 Europe intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 13 Germany intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 14 Germany intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 15 U.K. intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 16 U.K. intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 17 France intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 18 France intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 19 Spain intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 20 Spain intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 21 Italy intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 22 Italy intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 23 Russia intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 24 Russia intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 25 Asia Pacific intravenous iron drugs market, by country, 2016 - 2028 (USD Million)
Table 26 Asia Pacific intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 27 Asia Pacific intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 28 Japan intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 29 Japan intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 30 China intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 31 China intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 32 India intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 33 India intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 34 South Korea intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 35 South Korea intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 36 Singapore intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 37 Singapore intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 38 Australia intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 39 Australia intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 40 Latin America intravenous iron drugs market, by country, 2016 - 2028 (USD Million)
Table 41 Latin America intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 42 Latin America intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 43 Brazil intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 44 Brazil intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 45 Mexico intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 46 Mexico intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 47 Argentina intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 48 Argentina intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 49 MEA intravenous iron drugs market, by country, 2016 - 2028 (USD Million)
Table 50 MEA intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 51 MEA intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 52 South Africa intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 53 South Africa intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 54 Saudi Arabia intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 55 Saudi Arabia intravenous iron drugs market, by application, 2016 - 2028 (USD Million)
Table 56 UAE intravenous iron drugs market, by product, 2016 - 2028 (USD Million)
Table 57 UAE intravenous iron drugs market, by application, 2016 - 2028 (USD Million)


List of Figures

Fig. 1 Intravenous iron drugs market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Intravenous iron drugs market snapshot (2020)
Fig. 9 Intravenous iron drugs market: Segment snapshot (2020)
Fig. 10 Competitive Insights (2020)
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Intravenous iron drugs market driver impact
Fig. 15 Intravenous iron drugs market restraint impact
Fig. 16 Intravenous iron drugs market industry challenges
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 19 Strategic alliance analysis
Fig. 20 Recent developments & impact analysis, by key market participants
Fig. 21 Key company market share analysis, 2020
Fig. 22 Company market position analysis
Fig. 23 Definition and scope, by product
Fig. 24 Product market share analysis, 2020 & 2028
Fig. 25 Segment dashboard
Fig. 26 Global intravenous iron drugs market, by product, 2016 -2028 (USD Million)
Fig. 27 Iron Dextran market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 28 Ferric Carboxymaltose market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 29 Iron Sucrose market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 30 Others market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 31 Global intravenous iron drugs market, by application, 2016 -2028 (USD Million)
Fig. 32 Chronic Kidney Disease market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 33 Inflammatory Bowel Disease market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 34 Cancer market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 35 Other diseases market size & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 36 Intravenous iron drugs market: Snapshot, 2020
Fig. 37 North America intravenous iron drugs market share and leading players, 2020
Fig. 38 Europe intravenous iron drugs market share and leading players, 2020
Fig. 39 Asia Pacific intravenous iron drugs market share and leading players, 2020
Fig. 40 Latin America intravenous iron drugs market share and leading players, 2020
Fig. 41 Middle East and Africa intravenous iron drugs market share and leading players, 2020
Fig. 42 North America market share analysis by country, 2020
Fig. 43 Europe market share analysis by country, 2020
Fig. 44 Asia Pacific market share analysis by country, 2020
Fig. 45 Latin America market share analysis by country, 2020
Fig. 46 Middle East and Africa market share analysis by country, 2020
Fig. 47 North America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 48 Europe SWOT analysis, by factor (political & legal, economic and technological)
Fig. 49 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
Fig. 50 Latin America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 51 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
Fig. 52 North America market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 53 U.S. market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 54 Canada market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 55 Europe market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 56 U.K. market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 57 Germany market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 58 Spain market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 59 France market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 60 Italy market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 61 Russia market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 62 Asia Pacific market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 63 China market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 64 Japan market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 65 India market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 66 Australia market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 67 South Korea market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 68 Singapore market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 69 Latin America market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 70 Brazil market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 71 Mexico market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 72 Argentina market size, & forecasts and trend analysis, 2016 - 2028 (USD Million))
Fig. 73 Middle East and Africa market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 74 South Africa market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 75 Saudi Arabia market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)
Fig. 76 UAE market size, & forecasts and trend analysis, 2016 - 2028 (USD Million)